News

The trial is expected to begin enrollment in the fourth quarter of 2008 at three sites in Israel, and is designed to enroll a total of 30 patients

Mr Patriacca, currently an independent financial consultant, most recently served as vice president, CFO and Treasurer of MacroChem, a US-based publicly-traded specialty pharmaceutical company. Mr Patriacca has received

In less than one hour, Xpert MRSA/SA skin and soft tissue infections test processes specimens from suspected skin and soft tissue infection swabs to determine if a patient

The round was supported by an international syndicate of investors, led by Aravis Venture, a Swiss venture capital firm. Proquest Investments, a first tier US venture capital co-invested

The company has also introduced changes to its website, which presents current information about Limerick BioPharma and provides an overview of its proprietary efflux pump activators. Limerick has

The spin-off of the clinical and medical products businesses will create a new, global company headquartered in San Diego, with offerings for infusion, medication and supply dispensing, respiratory

These new patents relate to the company’s focus on the development of rapid and easy to use clinical diagnostic products. The first newly issued patent has broad applicability

The cost-cutting actions include a 33% decrease in headcount, from 43 to 29 employees, in the basic research and preclinical team and administrative support functions. Some outsourcing and

MedImmune will receive an upfront payment and has the potential to receive royalties on certain vaccine stockpiles or sales of other influenza products developed using the reverse genetics